Examinando por Materia "Tratamiento Farmacológico de COVID-19"

Mostrando 1 - 6 de 6

Acceso abierto
Diversidad de medicamentos usados en terapia COVID-19, en usuarios de boticas el Milagro. Distrito de Ventanilla – Provincia Callao. 2021–2022
(Universidad Privada Norbert Wiener, 2022-10-04) Mendoza López, Edgardo; Justil Guerrero, Hugo Jesús
Objective: To describe the diversity of medications most used for COVID-19 therapy among users visiting "El Milagro" drugstores. Method: This study used a quantitative approach, a basic type, a non-experimental design, and a descriptive level. A sample of 114 users was taken, and a survey was used as the data collection technique. Statistical analysis was performed using descriptive statistics with the contingency or cross-tabulation table for the respective variables. Results: The young adult age group (18-26 years) was the most frequent among users visiting the drugstores as well as regarding the diversity of medications most used for COVID-19 therapy. Regarding the diversity of most used medications, 28.1% of users presented signs and symptoms, 59.6% presented signs and symptoms of a certain intensity, 44.7% were young adults, and 53.5% were male.
Acceso abierto
Factores asociados al tratamiento con ceftriaxona en pacientes con COVID-19 atendidos en un centro médico de Lima, periodo de abril–junio, 2022
(Universidad Privada Norbert Wiener, 2024-05-24) Huamancha Alderete, Odaliz; Ramos Jaco, Antonio Guillermo
This study focuses on analyzing the factors associated with ceftriaxone treatment in COVID-19 patients at a medical center in Lima between April and June 2022. The objective was to identify the various elements that influence the effectiveness of ceftriaxone therapy in patients with COVID-19, through a detailed analysis of the associated factors that may affect treatment response, considering comorbidities, gender, and age. The results of this research are expected to contribute to a better understanding of pharmacotherapeutic management with ceftriaxone in COVID-19 patients, thereby optimizing care strategies and improving clinical outcomes in this context. This study aims to provide significant knowledge to support clinical decision-making and the continuous improvement of medical care in public health emergencies such as the COVID-19 pandemic.
Acceso abierto
Interacciones medicamentosas reales y potenciales de los psicofármacos en los pacientes del servicio de medicina COVID-19 del Hospital de Emergencia de Villa el Salvador Lima 2021
(Universidad Privada Norbert Wiener, 2022-03-16) Robles Huaranca, Ricardo Justiniano; Caldas Herrera, Emma
The objective of this study is to identify "the actual and potential drug interactions of psychotropic medications in patients in the COVID-19 Medicine Service at the Villa El Salvador Emergency Hospital during the months of February to July 2021." The study is deductive, retro-prospective, quantitative, applied, and observational with a cross-sectional design. A data collection form was used for 87 pharmacotherapeutic follow-ups in which psychotropic medications were prescribed for anxiety, depression, and insomnia. The results showed that the most significant indicator accounted for the highest frequency with 307 (89%) interactions. Regarding the pharmacodynamic indicator, it presented the highest frequency with 183 (53%) interactions. The "justified" indicator had the highest frequency with 252 (73%) interactions. The potential interaction indicator showed a higher frequency with 318 (92.2%) interactions. The rapid interaction indicator had the highest prevalence with 19 (5.5%) interactions. As for the probable interaction indicator, it presented the highest frequency with 25 (7.25%) actual interactions. Regarding gender, males exhibited 172 (49.9%) potential interactions, while females showed a higher incidence of actual interactions with 15 (4.3%) interactions. The average age was 48.58 years; for potential interactions, it was 48.83 years, and for actual interactions, it was 45.67 years. Sertraline accounted for 184 (53.2%) potential interactions, while mirtazapine showed the highest frequency of actual drug interactions with 12 (3.5%) interactions. It was concluded that the increase in psychotropic prescriptions is related to a higher likelihood of drug interactions.
Acceso abierto
Polifarmacia y factores asociados en el tratamiento de la COVID-19 en adultos de la Urbanización San Germán-La Victoria-Lima-2022
(Universidad Privada Norbert Wiener, 2023-02-02) Lipa Chavez, Nahayomi Solange; Mendoza Salcedo, Rildo Romario; Rojas Wisa, Oscar Favio
The objective of this study is to determine the relationship between polypharmacy and associated factors in the treatment of COVID-19 in adults from the San Germán Urbanization - La Victoria - Lima. Method: A quantitative approach, basic type, non-experimental design, and correlational level were used. The sample consisted of 293 citizens aged 25 to 44 years. Data collection was carried out using the survey technique, and statistical analysis was performed with SPSS Version 25.0 and the Spearman Correlation Coefficient, indicating the feasibility of continuing the research work. Result: Polypharmacy is related to the associated factors since the p-value is less than 0.05 (p-value = 0.000). Conclusion: The relationship between polypharmacy and associated factors in the treatment of COVID-19 in adults from the San Germán Urbanization - La Victoria - Lima - 2022 was determined.
Acceso abierto
Tratamiento farmacológico para el COVID-19 en pacientes que acudieron al Centro Médico Naval Cirujano Mayor Santiago Távara, Lima 2021
(Universidad Privada Norbert Wiener, 2022-10-05) Carhuas Rivera, Yobely Humbertha; Quinto Sanchez, Sandy; Parreño Tipián, Juan Manuel
This new disease, COVID-19, has been designated by the WHO as an infection caused by the novel coronavirus-19, which rapidly spread across China and subsequently affected countries worldwide, impacting both developed and underdeveloped nations with varying effects on public health. The main objective of this research was to determine the pharmacological treatments for COVID-19 in patients who visited the Naval Medical Center "Cirujano Mayor Santiago Távara" in Lima Province. A descriptive study was designed with a quantitative research approach, using a checklist as an instrument for data collection. A documentary analysis of medical records was conducted from October to December 2021, comprising a population of 1,008 adults. The results showed that 31.33% of patients were aged 41 to 50 years, with the majority being male (71.08%). Pharmacological treatments identified for COVID-19 included: Antibiotics such as azithromycin (50.60%) and ceftriaxone (40.96%), Analgesics and/or antipyretics such as paracetamol (97.60%) and metamizole sodium (73.49%), Anticoagulants such as enoxaparin 60mg (33.73%) and enoxaparin 40mg (30.12%), Corticosteroids such as dexamethasone (39.76%), Oxygen therapy using medicinal oxygen (87.95%). It is concluded that there is currently no specific scientific treatment to counter the progression of the SARS-CoV-2 coronavirus. Therefore, therapy is based on symptom control and support, following clinical guidelines provided by the Ministry of Health in each country and the WHO worldwide.
Acceso abierto
Uso de ivermectina para terapia del COVID-19 por los usuarios de la botica Reyesfarma del distrito de Lurín – Lima Metropolitana, primer semestre 2021
(Universidad Privada Norbert Wiener, 2022-01-17) Lino Fuentes, Erika Patricia; Reyes Altamirano, Deyvis Alvaro; Ramos Jaco, Antonio Guillermo
The objective of this research was to determine the characteristics of ivermectin use for COVID-19 therapy among users of the REYESFARMA drugstore in the Lurín district of Metropolitan Lima during the first semester of 2021. Method: The study used a quantitative approach with a basic type, a non-experimental design, and a correlational level in accordance with the scientific research procedure. The population consisted of 320 people, and a sample of 153 was used, to whom a questionnaire was applied via a survey. For statistical analysis, SPSS Version 25.0 and the test of symmetric measures and contingency coefficient were used. Results: A very strong positive association was found between the variable of ivermectin use and the intervening variable of COVID-19 therapy, with a contingency coefficient of 0.766 and a p-value of 0.001, which is less than 0.05. Conclusion: The characteristics of ivermectin use for COVID-19 therapy were determined, with 71.9% of users having a medium level of use with antiviral action, 15.7% having a strong antiviral action level of use, and 12.4% having a high antiviral action level of use.